Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

LUNG

Pulmonx (LUNG)

Pulmonx Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:LUNG
FechaHoraFuenteTítuloSímboloCompañía
17/05/202415:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUNGPulmonx Corporation
07/05/202416:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
06/05/202416:03GlobeNewswire Inc.Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LUNGPulmonx Corporation
01/05/202415:05GlobeNewswire Inc.Pulmonx Reports First Quarter 2024 Financial ResultsNASDAQ:LUNGPulmonx Corporation
10/04/202415:05GlobeNewswire Inc.Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024NASDAQ:LUNGPulmonx Corporation
02/04/202415:05GlobeNewswire Inc.Pulmonx Announces Appointment of Mehul Joshi as Chief Financial OfficerNASDAQ:LUNGPulmonx Corporation
07/03/202419:02Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:LUNGPulmonx Corporation
29/02/202415:31Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LUNGPulmonx Corporation
27/02/202415:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:LUNGPulmonx Corporation
26/02/202419:48Business WirePulmonx meldet Behandlung des ersten Patienten mit dem AeriSeal®-System in der CONVERT-II-ZulassungsstudieNASDAQ:LUNGPulmonx Corporation
26/02/202419:40Business WirePulmonx annonce le traitement du premier patient par système AeriSeal® dans l'essai pivot CONVERT IINASDAQ:LUNGPulmonx Corporation
26/02/202419:39Business WirePulmonx annuncia il trattamento del primo paziente con il sistema AeriSeal® nello studio pivotale CONVERT IINASDAQ:LUNGPulmonx Corporation
26/02/202407:00Business WirePulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal TrialNASDAQ:LUNGPulmonx Corporation
22/02/202415:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LUNGPulmonx Corporation
21/02/202415:06GlobeNewswire Inc.Pulmonx Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LUNGPulmonx Corporation
21/02/202415:05GlobeNewswire Inc.Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive OfficerNASDAQ:LUNGPulmonx Corporation
14/02/202405:17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:LUNGPulmonx Corporation
07/02/202415:05GlobeNewswire Inc.Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024NASDAQ:LUNGPulmonx Corporation
11/12/202308:00GlobeNewswire Inc.The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of DirectorsNASDAQ:LUNGPulmonx Corporation
15/11/202315:05GlobeNewswire Inc.Pulmonx to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:LUNGPulmonx Corporation
03/11/202315:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LUNGPulmonx Corporation
31/10/202315:05GlobeNewswire Inc.Pulmonx to Participate at Upcoming Investor ConferencesNASDAQ:LUNGPulmonx Corporation
30/10/202315:05GlobeNewswire Inc.Pulmonx Reports Record Third Quarter 2023 Financial ResultsNASDAQ:LUNGPulmonx Corporation
19/10/202315:38Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LUNGPulmonx Corporation
16/10/202315:05GlobeNewswire Inc.Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023NASDAQ:LUNGPulmonx Corporation
10/10/202315:05GlobeNewswire Inc.Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 RevenueNASDAQ:LUNGPulmonx Corporation
02/08/202315:05GlobeNewswire Inc.Pulmonx Reports Second Quarter 2023 Financial ResultsNASDAQ:LUNGPulmonx Corporation
26/07/202315:05GlobeNewswire Inc.Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:LUNGPulmonx Corporation
17/07/202307:00GlobeNewswire Inc.Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023NASDAQ:LUNGPulmonx Corporation
20/06/202317:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LUNGPulmonx Corporation
 Showing the most relevant articles for your search:NASDAQ:LUNG